Boston Scientific's Taxus Stent is a drug-coated coronary stent used in conjunction with angioplasty procedures. Taxus stents have been linked to blood clots that formed during and right after surgery that can cause death or stroke.
Stents are tiny mesh tubes used to prop open heart arteries after angioplasty, and are coated with paclitaxel, a drug licensed from Canada's Angiotech Pharmaceuticals Inc. that prevents scar tissue from forming around the metal stent.
Boston Scientific Corp., maker of the Taxus Stent, has expanded its voluntary recall of the stent because of possible defects in the delivery system. Impeded balloon deflation can result in coronary artery bypass graft surgery and death. The Company has received reports of one death and 18 serious injuries associated with balloon deflation for the Taxus stent system.
Boston Scientific said the design flaw involves the device used to insert the stent, not the stent itself, so patients with the stents are not at risk.
fill in our form on the right to submit your complaint.
If your injustice does not match the complaint described above, please use this form to register your complaint. Thank you.
